MedPath

Randomised Controlled Trial to determine the appropriate time to initiate peritoneal dialysis after insertion of catheter to minimise complications in end stage renal disease patients (Timely Peritoneal dialysis study)

Not Applicable
Completed
Conditions
Chroinc kidney disease complications
Renal and Urogenital - Kidney disease
Registration Number
ACTRN12610000076077
Lead Sponsor
Queensland Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
315
Inclusion Criteria

1. end stage kidney disease
2. patients likely to start peritoneal dialysis in the 4 weeks after insertion of a Tenckhoff catheter
4.surgical or peritoneoscopic insertion of a Tenckhoff catheter
5.18 yrs or over
6. able to give informed consent

Exclusion Criteria

1. patients with a history of psychological illness or condition which interferes with their ability to understand or comply with the requirements of the study.
2.recent (within 4 weeks ) acute infection.
3. patients in whom peritoneal dialysis is contraindicated or not desired

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Peritoneal fluid leaks and infection (over the four weeks following start up of peritoneal dialysis; Leak by observation during clinical examination; infection by chemical analysis of peritoneal dialysis fluid )[4 weeks from initiation of dialysis]
Secondary Outcome Measures
NameTimeMethod
Composite of all PD catheter related complications such as infection at exit site by clinical observation and will be confirmed by microbiological tests.[8 weeks from catheter insertion];Hemodialysis related complications such as infection and catheter related complications. These complications will be assessed by clinical examination/ tests[8 weeks from PD catheter insertion]
© Copyright 2025. All Rights Reserved by MedPath